Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Head & Neck 2Gynecologic 2Tumor-Agnostic 1Thoracic 1Myeloid 1Gastrointestinal 1Breast 1

Conditions

Metabolic Syndrome 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Diabetes Mellitus 1Cardiovascular Diseases 1

Interventions

Flow Cytometry 36Gene Expression Profiling 34Surveys and Questionnaires 27Polymerase Chain Reaction 24Microarray Analysis 23Blood Specimen Collection 19Interviews as Topic 18Imatinib Mesylate 15Amplified Fragment Length Polymorphism Analysis 14Reverse Transcriptase Polymerase Chain Reaction 13Cytogenetic Analysis 13Rituximab 12venetoclax 11nilotinib 10Psychiatric Rehabilitation 10Dasatinib 10Immunologic Techniques 9DNA Methylation 9Blotting, Western 9ponatinib 8Observation 8In Situ Hybridization, Fluorescence 8Base Sequence 8Azacitidine 8ibrutinib 7fludarabine 7bosutinib 7Watchful Waiting 7Therapeutics 7Specimen Handling 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × DNA × Other hematologic neoplasm × Clear all
NCT05605379 2024-08-14

CML Piramid

University Hospital, Bordeaux

Recruiting
88 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00566566 2007-12-03

Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors

Sheba Medical Center

Unknown
150 enrolled
Other hematologic neoplasm

Cardiovascular Diseases, Diabetes Mellitus, Leukemia, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡